Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single Center, Double-blind, Placebo Controlled, Phase 3 Trial . Acta Medica Philippina, [S. l.], v. 58, n. 6, 2024. DOI: 10.47895/amp.vi0.6175. Disponível em: https://actamedicaphilippina.upm.edu.ph/index.php/acta/article/view/6175. Acesso em: 24 apr. 2025.